QuicksortRx
QuicksortRx is a cloud-based SaaS platform delivering real-time pharmacy purchasing analytics, contract optimization, shortage intelligence, and 340B compliance tools to hospital and health system pharmacy teams. It serves 30+ U.S. health systems managing over $8 billion in annual pharmacy spend.
- Company typePrivate
- Founded2018
- HeadquartersCharleston, United States
- Headcount1–10
- GTM typeB2B
- OfferingSoftware
What QuicksortRx does
QuicksortRx is a cloud-based SaaS analytics platform built for hospital and health system pharmacy procurement teams. The platform ingests purchasing data directly from wholesalers and surfaces real-time visibility into enterprise-wide drug spend, contract discrepancies, price changes, 340B program performance, and drug availability. Core modules include a real-time analytics dashboard, contract change management with credit/rebill identification, crowdsourced shortage intelligence, 340B optimization, WAC Premium tracking (with a benchmarking "2% Club" recognizing customers below 2.9% WAC Premium), price-increase alerts, and actionable benchmarking across facilities. Notable technical components include QUMI (QuicksortRx Universal Medication Identifiers), open-source codes released on GitHub that merge openFDA and RxNorm data to determine operational NDC interchangeability at a more granular level than RxCUI, including unit size and vial-versus-ampule differentiation. The platform integrates with wholesalers directly and is designed for no-touch deployment, typically going live in under one month with zero customer IT resources.
The company sells via a subscription SaaS model, quote-based and not publicly disclosed, supported by high-touch professional services including weekly expert-led optimization meetings led by former health-system pharmacy supply chain leaders. Customers receive a free initial savings analysis and a 12-month savings estimate backed by a 100% money-back guarantee, materially de-risking the procurement decision. QuicksortRx serves 30+ U.S. health systems that collectively manage more than $8 billion in annual hospital pharmacy spend, with documented customer savings of $1.9M per customer on average in 2024 and $334M in cumulative validated savings across the base by Q1 2026. Distribution is a direct enterprise field sales motion targeting pharmacy and supply chain leadership, complemented by inside sales, conference presence (ASHP, 340B Coalition, IDN Summit, HCP), and a content-marketing engine including the IGQ podcast, blog, and KLAS-validated case studies.
The company was founded in 2018 by MUSC pharmacist and technologist staff (originally as AscendRx, rebranded in March 2020), is led by co-founders Jonathan Yantis (CEO) and Matt Hebbard (Vice President of Pharmacy), is Delaware-incorporated with headquarters in Charleston, South Carolina, and remains privately held. It is Best in KLAS for Purchasing Optimization Analytics in both 2025 and 2026, holds SOC 2 Type II and HIPAA certifications, and is a member of the End Drug Shortage Alliance.
QuicksortRx firmographics
Firmographics- Name
- QuicksortRx
- Legal name
- QuicksortRx Inc.
- Website
- https://quicksortrx.com
- Company type
- Private
- Founded year
- 2018
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- QuicksortRx is a cloud-based SaaS platform delivering real-time pharmacy purchasing analytics, contract optimization, shortage intelligence, and 340B compliance tools to hospital and health system pharmacy teams. It serves 30+ U.S. health systems managing over $8 billion in annual pharmacy spend.
- Ownership category
- akta.pro rank
QuicksortRx industry classification
Industry- Product category
- Hospital Pharmacy Purchasing Analytics
- NAICS
- Pharmacy Benefit Management and Other Third Party Administration of Insurance and Pension Funds (524292)
- SIC
- Services-Prepackaged Software (7372)
- akta.pro primary industry
- Medication Inventory, Procurement & Supply Chain (Pharmacy) (HLACAKAI)
- akta.pro secondary industries
- Pharmacy Benefit Management (PBM) & Formulary Management IT (HLACAKAD), Pharmacy Benefit Analytics, Reporting & Employer Consulting (HLAEAKAK)
Keywords
Where QuicksortRx is headquartered
LocationHeadquarters
- HQ city
- Charleston
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
QuicksortRx business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Marketing or Sales, Operations
Revenue model
- SaaS Subscription Platform: Subscription-based SaaS platform providing real-time pharmacy purchasing analytics and decision support. Revenue is recurring, likely billed annually. Includes free initial savings analysis and 12-month savings estimate backed by a 100% money-back guarantee, reducing customer acquisition risk.
- High-Touch Implementation & Ongoing Advisory Services: Weekly expert-led optimization meetings and pharmacy supply chain expert support included as part of the customer engagement model. Dedicated pharmacy account specialists and pharmacy supply chain experts provide ongoing guidance, troubleshooting, and strategy support.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Annual | Subscription-based SaaS with money-back guarantee |
Go-to-market motion2 records
Distribution channels2 records
Marketing channels7 records
QuicksortRx product offering
Product offeringCore offering
QuicksortRx provides a cloud-based SaaS pharmacy purchasing decision support platform that delivers real-time analytics, contract change management, drug shortage intelligence, WAC Premium tracking, 340B program optimization, and actionable benchmarking to hospital and health system pharmacy teams. The platform combines unbiased, real-time purchasing analytics with high-touch weekly pharmacist-led optimization meetings, requires zero IT resources from the customer, and is backed by a 100% money-back guarantee on 12-month savings estimates.
Product overview
QuicksortRx is a healthcare analytics platform that provides a unified real-time pharmacy purchasing decision support system. The core product is the QuicksortRx Platform, which integrates purchasing optimization analytics, contract change management, shortage intelligence, pricing alerts, and actionable benchmarking. Supporting offerings include QUMI Codes (open-source National Drug Code matching identifiers), the Shortage Intelligence service, and the 2% Club WAC Premium benchmarking program. The platform is delivered as a SaaS solution with high-touch weekly expert-led optimization meetings and no-touch IT integration.
Differentiator
Problem solved
Functional benefit
Products and services
- QuicksortRx Platform Cloud-based SaaS pharmacy purchasing decision support platform providing real-time analytics, contract change management, shortage intelligence, WAC Premium tracking, 340B program optimization, price increase alerts, and actionable benchmarking for hospital and health system pharmacy teams. Delivered with high-touch weekly pharmacist-led optimization meetings and no-touch wholesaler integration that requires zero IT resources from customers.
- QUMI Codes (QuicksortRx Universal Medication Identifiers) Open-source medication identifier codes that merge openFDA and RxNorm data to enable streamlined matching of two National Drug Codes (NDCs) and determination of their operational interchangeability. Always include unit size and differentiate between vials and ampules for more granular reporting than RxCUIs. Available as an open-source industry standard.
Quantifiable outcome
- $300M+ all-time savings across customer base (as of 2026)
- +9 more outcomes
Companies that use QuicksortRx
Customer profileNamed customers4 records
Segments2 records
Ideal customer profiles2 records
QuicksortRx technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature10 records
QuicksortRx partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- End Drug Shortage AlliancecoreQuicksortRx joined the End Drug Shortage Alliance in May 2023. Established in 2022, the alliance is a collaboration of healthcare industry stakeholders dedicated to solving pharmaceutical supply challenges that disrupt access to essential medications in the United States. The alliance focuses on transparency, quality, redundancy, and production of supplies to improve access to much-needed medications. QuicksortRx co-founder and CEO Jonathan Yantis represents the company as part of the alliance, contributing platform insights and shortage mitigation expertise.
Scale indicators11 records
Recent moves8 records
Expansion highlights5 records
QuicksortRx competitors and assessment
Company assessmentDirect peers
- Bluesight: Healthcare supply chain intelligence platform with drug shortage monitoring, controlled substance diversion analytics, and purchasing visibility. Directly competes with QuicksortRx's Shortage Intelligence and pharmacy analytics offerings.
- Sentry Data Systems: Provides 340B program management and pharmacy purchasing analytics to hospitals and health systems. Overlaps directly with QuicksortRx on 340B optimization, contract compliance, and drug cost analytics for hospital pharmacy.
- Verity Solutions: Offers 340B split-billing, contract pharmacy, and pharmacy purchasing analytics for hospitals. Closely competes with QuicksortRx's 340B and contract compliance modules serving similar hospital pharmacy buyers.
Emerging players
- CaptureRx: Specializes in 340B management and contract pharmacy solutions for hospitals and FQHCs. Adjacent competitor focused narrowly on the 340B slice of QuicksortRx's value proposition.
- Inmar Intelligence: Operates pharmaceutical reverse distribution and supply chain analytics serving health systems and manufacturers. Compares to QuicksortRx's drug shortage intelligence and pharmacy purchasing oversight modules.
- LogicStream Health: Healthcare analytics platform focused on medication utilization, formulary, and pharmacy workflow optimization. Emerging player with overlapping analytics capabilities for hospital pharmacy leaders.
Broad incumbents
- First Databank (FDB): Drug knowledge and medication decision support vendor used across hospital pharmacy. Adjacent incumbent providing underlying drug data infrastructure relevant to QuicksortRx's analytics.
- Wolters Kluwer (Medi-Span): Provides drug pricing, clinical drug data, and formulary tools widely used by hospital pharmacy. Adjacent incumbent whose pricing data underpins some QuicksortRx workflows and could be a channel or competitor.
- Craneware: Public company providing hospital revenue cycle, supply chain, and 340B analytics at scale. Broad incumbent whose pharmacy purchasing optimization suite competes with QuicksortRx inside larger health system portfolios.
- McKesson Corporation: Largest U.S. pharmaceutical distributor with extensive hospital pharmacy services and analytics. Strategic incumbent whose wholesaler data feeds QuicksortRx today and which could compete or partner depending on commercial posture.
Market position
Strengths5 records
Weaknesses4 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
QuicksortRx social profiles
Digital presenceQuicksortRx compliance and trust
Trust signalCompliance3 records
QuicksortRx financial estimates
Financial estimateRevenue estimate
Valuation estimate
QuicksortRx leadership team
Management profileNumber of profiles
Profiles5 records
QuicksortRx funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
QuicksortRx M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about QuicksortRx
What does QuicksortRx do?
QuicksortRx provides a cloud-based SaaS pharmacy purchasing decision support platform that delivers real-time analytics, contract change management, drug shortage intelligence, WAC Premium tracking, 340B program optimization, and actionable benchmarking to hospital and health system pharmacy teams. The platform combines unbiased, real-time purchasing analytics with high-touch weekly pharmacist-led optimization meetings, requires zero IT resources from the customer, and is backed by a 100% money-back guarantee on 12-month savings estimates.
Is QuicksortRx a public or private company?
QuicksortRx is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was QuicksortRx founded?
QuicksortRx was founded in 2018. It employs 1 to 10 people.
Where is QuicksortRx based?
QuicksortRx is headquartered in Charleston, United States, in the North America region.
How does QuicksortRx make money?
Two revenue lines are on record. SaaS Subscription Platform is the primary driver. The others are high-Touch Implementation & Ongoing Advisory Services.
Who are QuicksortRx's main competitors?
Direct peers on record are Bluesight, Sentry Data Systems and Verity Solutions. Emerging players are CaptureRx, Inmar Intelligence and LogicStream Health. Broad incumbents are First Databank (FDB), Wolters Kluwer (Medi-Span), Craneware and McKesson Corporation.
Does QuicksortRx have an API?
No public API is recorded for QuicksortRx.
What industry is QuicksortRx in?
QuicksortRx's product category is Hospital Pharmacy Purchasing Analytics. Its primary akta.pro industry code is HLACAKAI, Medication Inventory, Procurement & Supply Chain (Pharmacy), with a secondary code of HLACAKAD, Pharmacy Benefit Management (PBM) & Formulary Management IT. Its NAICS code is 524292 and its SIC code is 7372.